Commodities & Agriculture:
- Brent crude (UKOIL) futures were down $1.33, or -1.3%, at $98.27 a barrel by 1225 GMT
- U.S. West Texas Intermediate (WTI) crude (USOIL) fell $1.51, or -1.6%, to $92.83.
- Gold futures held around $1,803.50. Still, both instruments were set for mild gains this week, marked by a sharp fall in the dollar.
- Platinum futures fell -0.6%, while Silver retreated -0.4%.
- Dollar Index, which tracks the greenback against a basket of six other currencies, traded +0.1% higher at 105.045, but still significantly lower than last Friday’s peak of 106.93.
- USD/JPY climbing +0.3% to 133.36 as U.S. Treasury yields bounced off their recent lows.
- GBP/USD fell -0.1% to 1.2203 after data showed that the U.K. economy shrank in the second quarter for the first time in five quarters, but by a fraction less than expected.
- EUR/USD traded largely flat at 1.0316, with the single currency struggling to make any gains given the difficulties the Eurozone’s economy is having to battle.
During Market hours Yesterday — (Thursday – 11.08.2022):
- The Dow (Symbol: DIA) gained +0.15%. The S&P 500 (Symbol: SPY) maintained with no change 0.00%. and the Nasdaq (Symbol: QQQ) lost -0.57%.
- Six Flags (Symbol: SIX) — Shares dropped -18.7% after the theme park company sharply missed second-quarter earnings expectations. Six Flags reported earnings of 53 cents per share on revenue of $435 million. Analysts surveyed by Refinitiv forecast earnings of $1.01 per share on revenue of $519 million. The theme park operator attributed the miss to weak attendance, or a 22% drop in visitors.
- Walt Disney (Symbol: DIS) – Disney shares jumped +4.68% after the company posted better-than-expected results for the quarter on the top and bottom lines, helped by strong attendance at its theme parks and better-than-expected streaming numbers. The company also revealed a new pricing structure for its streaming service that includes an ad-supported tier.
- Pharma stocks –Shares of Pfizer (Symbol: PFE), GSK (Symbol: GSK) and Sanofi (Symbol: SNY) slipped -3.32%, -6.71% and -3.94% respectively as investors watched ongoing litigation around Zantac, a recalled heartburn medication. The drug was pulled from shelves in 2020 after the Food and Drug Administration found an impurity in Sanfoli’s version that could cause cancer.
- Ralph Lauren (Symbol: RL) – Shares of Ralph Lauren climbed +3.77%, continuing a rally that began after the company reported earnings earlier in the week that beat Wall Street’s expectations on the top and bottom lines.
- Bank stocks – Shares of Goldman Sachs (Symbol: GS), Wells Fargo (Symbol: WFC) and JPMorgan (Symbol: JPM) gained more than +1% Thursday, outperforming the broader market. The stocks may have been boosted by easing concerns about a recession after a second soft inflation report in a row.
- Vacasa (Symbol: VCSA) —Shares of Vacasa jumped +33.22% after the vacation rental services company boosted its full-year outlook, citing a surge in demand. The company also posted a quarterly profit, surprising Wall Street.
During Premarket hours today – (Friday – 12.08.2022):
- Illumina (Symbol: ILMN) – Illumina tumbled -15.1% in the premarket after the gene-sequencing technology company reported quarterly profit and revenue that was lower than expected and issued an outlook that was well short of analyst estimates. Illumina said a challenging economic environment is offsetting growth in the use of its gene-sequencing platform.
- Toast (Symbol: TOST) – Toast surged +15.3% in premarket action after the restaurant payment technology company raised its full-year earnings outlook. Toast reported a quarterly loss, but it was narrower than analysts had predicted, with Toast noting a record number of new locations using its technology.
- Olo (Symbol: OLO) – Olo plunged -33% in premarket trading after the restaurant software maker issued a weaker-than-expected current quarter and full-year revenue outlook.
- LegalZoom (Symbol: LZ) – LegalZoom added +2.1% in the premarket after the purveyor of online legal forms reported better than expected quarterly earnings.
*Any information contained in this article, including any information contained in external third party links, if any, is solely for informational purposes and does not contain, or should not be construed as containing, investment advice or an investment recommendation, or, an offer of or solicitation for any transactions in financial instruments. Past performance does not guarantee or predict future performance. Colmex Pro Ltd does not take into account your personal investment objectives or financial situation and makes no representation, and assumes no liability to the accuracy or completeness of the information provided, nor for any loss arising from any investment based on presented information.